Samples from those who had COVID-19 could illuminate true infection rate, lethality, and vaccines

VirScan, a new antibody detection tool, can analyze blood samples collected from people who have recovered from COVID-19 to learn about how the virus affects the immune system and the epidemiology of the infection.

from Neuroscience News https://ift.tt/33Rdvsl